Esperion Therapeutics (ESPR) Q1 2025 Earnings

4MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.33
-0.11
0.12
0.34

Details

Expected EPS
-0.148562
Actual EPS
-0.11
Surprise EPS
0.04
Surprise Percent
+25.96%

Description

Esperion Therapeutics (ESPR) has reported earnings of -0.11 per share for Q1 2025.

0 Comments

Share your thoughts